002793.SZ
002793.SZ
CNE1000026S7
LUOXINPHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.273.457.651 2.647.365.106
14.1%
Cost of Revenue 1.144.712.765 1.531.648.273
25.3%
Gross Profit 1.128.744.886 1.115.716.833
1.2%
1.270.299.534 1.485.734.168
14.5%
Operating Income -141.554.648 -370.017.335
61.7%
Pretax Income -290.871.969 -952.854.882
69.5%
Net Income Common Stockholders -288.580.203 -965.496.164
70.1%
-- --
--
-- --
--
ende